These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25171154)

  • 1. The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy.
    Carnovale C; Brusadelli T; Zuccotti G; Beretta S; Sullo MG; Capuano A; Rossi F; Moschini M; Mugelli A; Vannacci A; Laterza M; Clementi E; Radice S;
    Expert Opin Drug Saf; 2014 Sep; 13 Suppl 1():S1-8. PubMed ID: 25171154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
    Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
    Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance.
    Sessa M; Rossi C; Mascolo A; Grassi E; Fiorentino S; Scavone C; Reginelli A; Rotondo A; Sportiello L
    Expert Opin Drug Saf; 2015; 14(9):1341-51. PubMed ID: 26156557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are non-serious adverse reactions to psychiatric drugs really non-serious?
    Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 - 2012.
    Ferrajolo C; Capuano A; Trifirò G; Moretti U; Rossi F; Santuccio C
    Expert Opin Drug Saf; 2014 Sep; 13 Suppl 1():S9-20. PubMed ID: 25171155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active drug monitoring of adverse drug reactions in pediatric emergency department].
    Planchamp F; Nguyen KA; Vial T; Nasri S; Javouhey E; Gillet Y; Ranchin B; Villard F; Floret D; Cochat P; Gueyffier F; Kassaï B;
    Arch Pediatr; 2009 Feb; 16(2):106-11. PubMed ID: 19117738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.
    Fabiano V; Mameli C; Zuccotti GV
    Expert Opin Drug Saf; 2012 Jan; 11(1):95-105. PubMed ID: 21548838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population.
    Bygdell M; Brunlöf G; Wallerstedt SM; Kindblom JM
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):79-86. PubMed ID: 22076661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain.
    D'Incau P; Lapeyre-Mestre M; Carvajal A; Donati M; Salado I; Rodriguez L; Sáinz M; Escudero A; Conforti A
    Fundam Clin Pharmacol; 2014 Jun; 28(3):342-8. PubMed ID: 23617454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions: trends in a tertiary care hospital.
    Rehan HS; Chopra D; Sah RK; Mishra R
    Curr Drug Saf; 2012 Nov; 7(5):384-8. PubMed ID: 23150923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily.
    Nasso C; Mecchio A; Rottura M; Valenzise M; Menniti-Ippolito F; Cutroneo PM; Squadrito V; Squadrito F; Pallio G; Irrera N; Arcoraci V; Altavilla D
    Front Pharmacol; 2020; 11():1090. PubMed ID: 32765282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
    Ladewski LA; Belknap SM; Nebeker JR; Sartor O; Lyons EA; Kuzel TC; Tallman MS; Raisch DW; Auerbach AR; Schumock GT; Kwaan HC; Bennett CL
    J Clin Oncol; 2003 Oct; 21(20):3859-66. PubMed ID: 14551305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.
    Fracchiolla NS; Artuso S; Cortelezzi A; Pelizzari AM; Tozzi P; Bonfichi M; Bocchio F; Gargantini L; De Rosa E; Vighi GD; Prestini L; Sammassimo S; Frungillo N; Pasquini MC; Ragazzi A; Boghi D; Pastore A; Lanzi E; Gritti G; Quaresmini G; Voltolini S; Gaiardoni R; Corti C; Vilardo MC; La Targia ML; Berini G; Magagnoli M; Bacci C; Consonni D; Rivolta AL; Muti G
    Hematol Oncol; 2018 Feb; 36(1):299-306. PubMed ID: 28771763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database.
    Jiao Z; Feng Z; Yan Z; Zhang J; Li G; Wang G; Wang Q; Feng D
    Front Oncol; 2021; 11():807171. PubMed ID: 34988029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden.
    Ufer M; Kimland E; Bergman U
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):147-52. PubMed ID: 15072113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.
    Viola E; Trifirò G; Ingrasciotta Y; Sottosanti L; Tari M; Giorgianni F; Moretti U; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):61-67. PubMed ID: 27875919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A retrospective pharmacovigilance analysis: could decreased reporting of suspected adverse reactions generate future safety concerns?].
    Ferrara F; Mancaniello C; Nava L; Salierno A; Casillo R; Trama U; Nava E; Vitiello A
    Recenti Prog Med; 2022 Mar; 113(3):198-201. PubMed ID: 35315450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.